跳至主要内容
临床试验/NCT03869151
NCT03869151Unknown不适用

The Impact of Pretreatment Lymphocyte to Monocyte Ratio on Clinical Outcome for Patient With HCC

Amany Aboalenen Amin0 个研究点目标入组 1 人开始时间: 2019年4月5日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
1
主要终点
increased over all survival

研究概览

简要总结

To assess the prognostic role of pretreatment LMR in hepatocellular carcinoma(HCC).

详细描述

The exact molecular mechanisms responsible for the prognostic impact of lymphocyte monocyte ratio in Heatocellular carcinoma are unclear.It has been suggested that cross-talk between the inflammatory response and tumor progression play a critical role in the initiation and progression of Heatocellular carcinoma. In the tumor microenvironment, inflammatory infiltrates have a large influence on the biological behavior of Heatocellular carcinoma.

Tumor-infiltrating lymphocytes, as representative component of the immune microenvironment ,are implicated in several stages of Heatocellular carcinoma progression, and Tumor-infiltrating lymphocytes phenotypes may be a predictor for favorable prognosis.

Conversely, low lymphocyte counts might result in an insufficient immunological reaction, which lead to inferior survival in multiple cancers.

Monocytes infiltrating tumor tissue are also involved in Heatocellular carcinoma development and progression. Activated monocytes in Heatocellular carcinoma micro environments can trigger and polarize T-cell responses and facilitate inflammation-induced tumor development.

Tumor-associated macrophages are derived from circulating monocytes. Tumor-associated macrophages can accelerate Heatocellular carcinoma cell proliferation,tumor-associated angiogenesis, and metastasis. Several studies showed that high infiltration of Tumor-associated macrophages predicted decreased survival in various cancers.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with child A Hepatocellular carcinoma.

排除标准

  • Patients with child C Hepatocellular carcinoma.
  • Patients with heart failure

结局指标

主要结局

increased over all survival

时间窗: 1 year

Elevated pretreatment lymphocyte monocyte ratio may be a favorable prognostic factor for clinical outcomes in patients with hepatocellular carcinoma.

次要结局

未报告次要终点

研究者

发起方
Amany Aboalenen Amin
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Amany Aboalenen Amin

Principal Investigator

Assiut University

相似试验